Halozyme Therapeutics shares owned by Wiley Bros.-aintree Capital
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Wiley Bros.-aintree Capital
from 13F filings
Historical chart of Wiley Bros.-aintree Capital investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Wiley Bros.-aintree Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $150k | 131k | 1.14 |
| 2025-06-30 | $137k | 138k | 0.99 |
| 2025-03-31 | $148k | 140k | 1.06 |
| 2024-12-31 | $137k | 144k | 0.95 |
| 2024-09-30 | $143k | 143k | 1.00 |
| 2024-06-30 | $77k | 81k | 0.95 |
More positions owned by Wiley Bros.-aintree Capital
View all positions for Wiley Bros.-aintree Capital